BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7831151)

  • 1. Lysosomal storage diseases in adults.
    Rapola J
    Pathol Res Pract; 1994 Sep; 190(8):759-66. PubMed ID: 7831151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What can cell biology tell us about heterogeneity in lysosomal storage diseases?
    Gieselmann V
    Acta Paediatr Suppl; 2005 Mar; 94(447):80-6; discussion 79. PubMed ID: 15895717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS; Mirenburg TV; Krasnopolskaya XD
    J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypes in heteroglycanoses and sphingolipidoses (author's transl)].
    Gehler J
    Monatsschr Kinderheilkd; 1981 Nov; 129(11):610-20. PubMed ID: 6798422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
    Dawson G; Chen Tsay G
    Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
    [No Abstract]   [Full Text] [Related]  

  • 7. Gangliosidoses.
    Patterson MC
    Handb Clin Neurol; 2013; 113():1707-8. PubMed ID: 23622392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in the diagnosis and treatment of lysosomal storage diseases].
    Wu XR; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):440-4. PubMed ID: 16086072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of different forms of metachromatic leukodystrophy.
    Polten A; Fluharty AL; Fluharty CB; Kappler J; von Figura K; Gieselmann V
    N Engl J Med; 1991 Jan; 324(1):18-22. PubMed ID: 1670590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosphingolipid disorders of the brain.
    Boomkamp SD; Butters TD
    Subcell Biochem; 2008; 49():441-67. PubMed ID: 18751922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.
    Kohyama M; Yabuki A; Ochiai K; Nakamoto Y; Uchida K; Hasegawa D; Takahashi K; Kawaguchi H; Tsuboi M; Yamato O
    BMC Vet Res; 2016 Mar; 12():67. PubMed ID: 27036194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis.
    Sandhoff K; Harzer K
    J Neurosci; 2013 Jun; 33(25):10195-208. PubMed ID: 23785136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited neuropathies related to disorders of lipid metabolism.
    Thomas PK
    Adv Neurol; 1988; 48():133-44. PubMed ID: 2446477
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue].
    Pilz H; Heipertz R
    Fortschr Neurol Psychiatr Grenzgeb; 1975 Nov; 43(11):602-17. PubMed ID: 53174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases.
    Xia B; Asif G; Arthur L; Pervaiz MA; Li X; Liu R; Cummings RD; He M
    Clin Chem; 2013 Sep; 59(9):1357-68. PubMed ID: 23676310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal models for inborn lysosomal storage diseases (author's transl)].
    Naiki M
    Jikken Dobutsu; 1977 Jan; 26(1):65-77. PubMed ID: 404167
    [No Abstract]   [Full Text] [Related]  

  • 17. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.
    Meek D; Wolfe LS; Andermann E; Andermann F
    Ann Neurol; 1984 Apr; 15(4):348-52. PubMed ID: 6430210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.
    Ikonen E; Peltonen L
    Hum Mutat; 1992; 1(5):361-5. PubMed ID: 1301945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidoses detected in Poland through 1993.
    Czartoryska B; Tylki-Szymañska A; Górska D; Sawnor-Korszyñska D
    Pediatr Neurol; 1994 Nov; 11(4):295-7. PubMed ID: 7702688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.